Skip to main content

ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban

User login

Username

Password

Reset your password

Type	Lead	score